Back
Open Access

Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure

Session: Late breaking trial II - Chronic heart failure
Topic: Hypertension, Other
Speaker: Professor P. Rossignol (Vandoeuvre-Les-Nancy, FR)
Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Congress Session

0

About the speaker

Professor Patrick Rossignol

University of Lorraine, Vandoeuvre-Les-Nancy (France)
10 presentations
1 follower

12 more presentations in this session

Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial

Speaker: Professor M. Schulz (Berlin, DE)

Access
Slides
Video
0
Thumbnail

Discussion - PHARM-CHF

Access
Video
0
Thumbnail

Discussion - AMBER.

Access
Video
0
Thumbnail

Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

Speaker: Doctor A. Biolo (Porto Alegre, BR)

Access
Slides
Video
0
Thumbnail

Discussion - Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

Access
Video
0
Thumbnail

Access the full session

Late breaking trial II - Chronic heart failure

Speakers: Professor P. Rossignol, Professor M. Schulz, Doctor A. Biolo
Access
0
Thumbnail

About the event

Image

Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

This platform is supported by

logo Novo Nordisk